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Abstract Fanconi-Bickel Syndrome (FBS) is a rare autoso-
mal recessive disorder of carbohydrate metabolism. The de-
fect in the GLUT 2 receptors in the hepatocytes, pancreas and
renal tubules leads to symptoms secondary to glycogen stor-
age, glucose metabolism and renal tubular dysfunction.
Derangement in glucose metabolism is classical with fasting
hypoglycemia and post-prandial hyperglycemia. The authors
report a 4-year-old boy who presented with failure to thrive,
motor delay, protuberant abdomen and was noted to have
huge hepatomegaly with glycogen deposition in liver, and
renal tubular acidosis. Gene sequencing revealed homozygous
mutation, c.1330T > C in SLC2A2 gene, thus confirming the
diagnosis of FBS. Only three mutations have been reported
from India so far. The primary reason for referral to authors’
hospital was for liver transplantation, but an accurate diagno-
sis led to avoidance of the major surgery and streamlining of
treatment with clinical benefit to the child and family.
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Introduction
Fanconi-Bickel Syndrome (FBS), a rare genetic disorder of carbo-
hydrate metabolism, was first described by Fanconi and Bickel in
1949 [1]. The authors report a case of FBS presenting at 4 y of age
whose correct diagnosis led to avoidance of the liver transplant.
Case Report
A 4-year-old boy, born to third degree consanguineous couple
(first cousins), fromMaharashtra presented with failure to thrive,
delayed mile stones and progressive abdominal distention since
infancy. There was no history of seizures or jaundice. The child
had cherubic facies, height of 81 cm (<3rd percentile) andweight
10.8 kg (<3rd percentile). Features of active rickets (wrist wid-
ening, frontal bossing and hypotonia) were present (Fig. 1). His
developmental age corresponded to 2 y. Soft hepatomegaly was
observed with liver span of 15 cm; no splenomegaly or evidence
of ascites was noted. Systemic examination was otherwise unre-
markable. Investigations revealed normal blood counts, includ-
ing absolute neutrophils, metabolic acidosis (pH 7.23, bicarbon-
ate 16.9 mmol/L), hyperchloremia (113.9 mmol/L) and normal
anion gap. GSD Ia was ruled out after gene sequencing.
Evidence of proximal renal tubular acidosis (RTA) was noted
(generalized aminoaciduria on thin layer chromatography,
glucosuria +++ and proteinuria ++). Total cholesterol was
249 mg/dl (normal: <195) and triglycerides were 681 mg/dl
(<145). Post-prandial and post glucose hyperglycemia was doc-
umented on two occasions (246 mg/dl and 252 mg/dl) after
episode of hypoglycemia (40 mg/dl). Fasting plasma lactate
was 10.2 mg/dl (4.5–20 mg/dl). Liver function tests (serum
proteins, bilirubin, ALT, AST) including prothrombin time were
normal. Blood urea nitrogen, creatinine and uric acid were
normal (10, 0.6 and 2.9 mg/dl, respectively). Serum calcium
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was 8.5 mg/dl, phosphorus was 2.0 mg/dl (2.5–4.6) and alkaline
phosphatase level was high 1044 (117–390). Wrist radiograph
showed features of rickets. His abdominal ultrasonography
revealed hepatomegaly with coarse echotexture. Liver biopsy
showed accumulation of glycogen in hepatocytes with no distur-
bance in liver architecture. In view of features of RTA, rickets,
hepatomegaly, fasting hypoglycemia and postprandial hypergly-
cemia, glycogen accumulation in liver, a diagnosis of FBS was
suspected. Sanger sequence analysis was performed for SLC2A2
gene, which revealed a previously reported homozygous muta-
tion, c.1330T > C in exon 10, resulting in change of amino acid
from Tryptophan to Arginine at 444 amino acid position
(p.Trp444Arg), thus confirming the diagnosis of FBS (Fig. 2).
After establishment of diagnosis, the family was counseled re-
garding the conservative management and liver transplant was
avoided. Dietary management was started with uncooked corn
starch and elimination of lactose in diet. Supplementation with
Vitamin D, phosphorus, and bicarbonate were added. On follow
up after 3 mo the child showed improvement in rickets and gain
ofweight and height (weight 12.2 kg and height 83 cm), however
with persistence of aminoaciduria.
Discussion
FBS is a rare disease of carbohydrate metabolism (previously
termed as glycogen storage disease type XI) occurring due to
pathogenic mutations in GLUT 2 transporter gene, SLC2A2.
Genetic defect in GLUT2 was proposed as the possible met-
abolic basis for FBS by Santer et al. in 1997 [2].
GLUT2 is amongst family of monosaccharide transporters
that transport sugars in an energy-independent manner.
GLUT2 transports glucose and galactose into hepatocytes
after feeding and exports free glucose out of hepatocytes
during fasting [2]. The hyperglycemia and hypergalactosemia





Fig. 2 Sequence chromatogram showing single homozygous base pair change, c.1330T>C (p.W444R) in SLC2A2 gene
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seen in postprandial state are due to reduced uptake of these
monosaccharides by the liver and may be enhanced by the
poor insulin response to elevated blood glucose levels dem-
onstrated in patients with FBS. Fasting hypoglycemia results
from defective export of free glucose from hepatocytes when
peripheral glucose supplies have been exhausted [2].
Glycosuria is the result of failure to export glucose across
the basolateral membranes of renal tubular cells.
Patients of FBS typically present with combination of clin-
ical symptoms: hepatomegaly secondary to glycogen accumu-
lation, glucose and galactose intolerance, fasting hypoglycemia,
a characteristic tubular nephropathy, and severely stunted
growth [3]. Patients presenting late develop cherubic face,
truncal obesity, retarded growth and puberty, bone problems
associated with hypophosphatemic rickets, and dental caries.
There is no specific treatment of FBS, the management for
renal Fanconi syndrome includes management of RTA with
maintenance of water and electrolyte balance; supplementa-
tion of vitamin D, calcium, phosphorus, and bicarbonate.
Small frequent meals with uncooked cornstarch, is advocated
[4]. The prognosis for this condition appears to be generally
good in terms of survival, but these patients are universally
short in stature. Liver transplant is not required for manage-
ment of patients suffering from FBS.
FBS has only been reported in a few cases from India, all
from consanguineous families presenting similarly with hepa-
tomegaly and renal dysfunction [5–8]. All mutations have
been shown to be different, thus showing lack of any common
mutation in India [6–8]. Genetic counseling is an integral part
of management in view of autosomal recessive nature of the
condition and 25 % risk of recurrence in siblings. With the
knowledge of mutations prenatal diagnosis can be offered to
couples in subsequent pregnancies, using mutation analysis
on chorionic villous sampling at 11 wk of pregnancy.
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